Form 8-K - Current report:
SEC Accession No. 0001493152-25-009731
Filing Date
2025-03-10
Accepted
2025-03-10 17:21:53
Documents
43
Period of Report
2025-03-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44001
2 ex99-1.htm EX-99.1 13858
3 ex99-2.htm EX-99.2 41114
4 ex99-2_001.jpg GRAPHIC 244538
5 ex99-2_002.jpg GRAPHIC 520211
6 ex99-2_003.jpg GRAPHIC 295082
7 ex99-2_004.jpg GRAPHIC 247559
8 ex99-2_005.jpg GRAPHIC 346365
9 ex99-2_006.jpg GRAPHIC 302237
10 ex99-2_007.jpg GRAPHIC 377774
11 ex99-2_008.jpg GRAPHIC 294400
12 ex99-2_009.jpg GRAPHIC 320495
13 ex99-2_010.jpg GRAPHIC 334524
14 ex99-2_011.jpg GRAPHIC 374336
15 ex99-2_012.jpg GRAPHIC 372824
16 ex99-2_013.jpg GRAPHIC 280167
17 ex99-2_014.jpg GRAPHIC 339584
18 ex99-2_015.jpg GRAPHIC 200658
19 ex99-2_016.jpg GRAPHIC 271748
20 ex99-2_017.jpg GRAPHIC 376450
21 ex99-2_018.jpg GRAPHIC 356927
22 ex99-2_019.jpg GRAPHIC 265004
23 ex99-2_020.jpg GRAPHIC 188930
24 ex99-2_021.jpg GRAPHIC 317646
25 ex99-2_022.jpg GRAPHIC 300877
26 ex99-2_023.jpg GRAPHIC 356065
27 ex99-2_024.jpg GRAPHIC 283496
28 ex99-2_025.jpg GRAPHIC 288150
29 ex99-2_026.jpg GRAPHIC 369687
30 ex99-2_027.jpg GRAPHIC 461565
  Complete submission text file 0001493152-25-009731.txt   12292280

Data Files

Seq Description Document Type Size
31 XBRL SCHEMA FILE cldi-20250310.xsd EX-101.SCH 3813
32 XBRL DEFINITION FILE cldi-20250310_def.xml EX-101.DEF 26683
33 XBRL LABEL FILE cldi-20250310_lab.xml EX-101.LAB 36817
34 XBRL PRESENTATION FILE cldi-20250310_pre.xml EX-101.PRE 25307
45 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5761
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 25724918
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)